Behandlung der chronischen Pouchitis mit Vedolizumab
Florian Bär(University of Lübeck), Ulf Helwig(Clinical Research Center Kiel), Johannes Bethge(Christian-Albrechts-Universität zu Kiel), Klaus Fellermann(Apple (Israel)), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), Niels Teich(Leipzig University), Jürgen Büning(University Hospital Schleswig-Holstein), Jochen Maul(Humboldt-Universität zu Berlin), Andreas Stallmach(Jena University Hospital), N.A. Dietrich(University Hospital Schleswig-Holstein), T Krause, Tanja Kühbacher(University Hospital Schleswig-Holstein), Carsten Büning(Charité - Universitätsmedizin Berlin), Christian Maaser(Klinikum Lüneburg)
Cited by 0
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k